Vascular thromboses with retroperitoneal fibrosis: a case report
Tóm tắt
Granulomatosis with polyangiitis is a systemic inflammatory disease characterized by necrotizing vasculitis that affects small- and medium-sized blood vessels. Granulomatous inflammation affects the lungs, ears, nose, and throat, and commonly affects the kidneys, although the retroperitoneal tissue is rarely affected. Several studies have reported an increased risk of venous thromboembolism. Early diagnosis and treatment are of vital importance due to the rapid progression of the disease.
We present the case of a 66-year-old Moroccan man followed for bilateral jugular thrombosis. Cavitary pulmonary nodules and retroperitoneal fibrosis with thrombosis involving several vascular territories were detected on thoracoabdominopelvic computerized tomography scan. Laboratory analyses revealed that the patient was positive for cytoplasmic antineutrophilic antibodies. The diagnosis of granulomatosis with polyangiitis was retained. Treatment with glucocorticoids and immunosuppressive agents resulted in significant clinical and radiological improvement over the following months. We describe the diagnostic steps and the difficulty of managing this patient. Rare manifestations, such as retroperitoneal fibrosis, have been reported in the literature in association with granulomatosis with polyangiitis, and should not delay the diagnosis and treatment of granulomatosis with polyangiitis owing to its severity.
Tài liệu tham khảo
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2012;65(1):1–11.
Revilla EMG, Fernandez AA, Ramirez MTR, Pardo SC, Moragues MAJ. Retroperitoneal fibrosis with periaortitis: a case report of an unusual form of presentation of granulomatosis with polyangiitis. Respir Med Case Rep. 2016; 121-4
Faurschou M, Mellemkjaer L, Sorensen IJ, Thomsen BS, Dreyer L, Baslund B. Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis. Arthritis Rheum. 2009;60:1187–92.
Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr, et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener’s Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med. 2005;142:620–6.
Berti A. Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20 year population-based cohort study. Mayo Clin Proc. 2018;93(5):597–606.
Gibelin A, Maldini C, Mahr A. Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome, and Goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med. 2011;32:264–73.
Berti A, Matteson EL, Crowson CS, Specks U, Cornec D. Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20-year population-based cohort study. Mayo Clin Proc. 2018;93:597–606.
Allenbach Y, Seror R, Pagnoux C, et al. High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68:564–7.
Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913.’ Arch Intern Med. 1997;157:1665–70.
Kronbichler A, Leierer J, Leierer G, Mayer G, Casian A, Höglund P, et al. Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides. Rheumatology (Oxford). 2017;56:704–8.
Somer T. Thrombo-embolic and vascular complications in vasculitis syndromes. Eur Heart J. 1993;14:24–9.
Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflammation by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2006;17:1235–42.
Jordan JM, Allen NB, Pizzo SV. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. Am J Med. 1987;82:397–400.
Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener’s granulomatosis. The long-term renal outcome in patients with glomerulonephritis. Arthritis Rheum. 2001;43:8.
Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833–9.
Koo BS, Koh YW, Hong S, et al. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol. 2015;25:194–8.
Fujii K, Hidaka Y. Churg-strauss syndrome complicated by chronic periaortitis: a case report and review of the literature. Intern Med. 2012;51:109–12.
Izzedine H, Servais A, Launay-Vacher V, Deray G. Retroperitoneal fibrosis due to Wegener’s granulomatosis: a misdiagnosis as tuberculosis. Am J Med. 2002;113:164–6.